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Abstract. To study the influence of endothelium derived 
relaxing factor/nitric oxide (EDNO) on renin gene ex- 
pression, the effects of a 2-day treatment with the NO- 
synthase inhibitor nitro-L-arginine-methylester (L-
NAME, 40 mg/kg twice a day) on plasma renin activity 
(PRA) and renal and adrenal renin m-RNA levels were 
examined in conscious rats with and without unilateral 
renal clips (0.2 ram). In sham-clipped animals L-NAME 
led to a decrease of PRA from 7.5 to 2.5 ng angiotensin 
I (ANGI) 9 h -1 9 m1-1 and to a 35% decrease of renal 
renin m-RNA levels. Unilateral renal artery clipping 
increased PRA to 35 and to 13 ng ANGI. h -1 9 m1-1 in 
vehicle and in L-NAME-treated rats, respectively. In the 
clipped kidneys renin m-RNA levels increased to 450% 
of control values in vehicle-treated animals and to 220% 
of control values in L-NAME-treated animals. In the 
contralaterals as opposed to clipped kidneys, renin 
m-RNA levels decreased to 16% and 50% of the control 
values in vehicle- and in L-NAME-treated animals, 
respectively. In the adrenal glands renin m-RNA levels 
were not significantly changed either by clipping of one 
renal artery or by treatment of animals with L-NAME. 
The NO-donor sodium nitroprusside (100 ~tM) was 
found to increase renin secretion and renin m-RNA 
levels in primary cultures of renal juxtaglomerular cells. 
These findings suggest hat EDNO is involved in the 
control of the renin gene by the renal perfusion pressure. 
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Introduction 
There is accumulating evidence that endothelium de- 
rived relaxing factor (EDRF), which is considered to be 
nitric oxide (NO), is a potent modulator of renin secre- 
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tion from the kidneys [1, 8, 11, 15, 16, 18, 23, 24, 27], 
A potential physiological role of EDRF/NO (or EDNO) 
in the control of renin secretion is, moreover, suggested 
by the high level expression of NO-synthase in renal 
macula densa cells [14, 26, 28], which are directly adja- 
cent to juxtaglomerular (JG) cells which produce, store 
and release renin in a regulated fashion [9]. The precise 
effect of EDNO on renin secretion, however, is still a 
matter of controversy. Thus, there are on the one hand 
reports of data obtained with anaesthetized rats [24] and 
with renal slices [1, 27] suggesting that EDNO exerts an 
inhibitory effect on renin secretion. There are on the 
other hand findings obtained from conscious [18] and 
anaesthetized dogs [16], isolated perfused rat kidneys [8, 
15, 23] and from isolated renal JG cells [11] suggesting 
that EDNO is a potent stimulator of renin secretion. The 
studies with the dogs and the isolated rat kidneys, more- 
over, strongly suggest that EDNO is essentially involved 
in the enhancement of renin secretion in response to a 
fail in renal artery pressure, a phenomenon that is com- 
monly referred to as to the "baroreceptor-control" f 
renin secretion. 
Although the linkage between renin secretion, renin 
synthesis and renin gene expression on the level of JG 
cells is not well understood, there is evidence for a con- 
cordant control of renin secretion and renin m-RNA lev- 
els by renal perfusion pressure [13]. In view of the pro- 
found effects of EDNO on pressure-related renin secre- 
tion it appeared reasonable, therefore, to also consider a 
potential role of EDNO on renin gene expression i  this 
context. 
We have addressed this question by examining the 
effect of the NO-synthase inhibitor nitro-L-arginine 
methylester (L-NAME) on renin m-RNA levels in con- 
scious rats with and without unilateral renal artery steno- 
sis. 
Our findings strongly suggest that EDNO is an acti- 
vator of renin gene expression in the kidney and is in- 
volved in the baroreceptor-control of renin gene expres- 
sion. 
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Materials and methods 
Animals. Male Sprague Dawley rats weighing 180-220 g were 
used for the experiments. Animals had free access to normal food 
(Altromin) and tap water. 
Time course of renal renin m-RNA levels after unilateral renal 
artery clipping. A total of 16 animals were anaesthetized with 
methohexital (50 mg/kg) and the left kidney was exposed by an 
abdominal incision. Sterile silver clips (Degussa, Germany) with 
an inner diameter of 0.2 mm were then placed on the left renal 
arteries. After 1, 2, 5 and 10 days four rats each were killed by 
decapitation and kidneys were rapidly removed. Kidneys were 
weighed, cut in half and frozen in liquid nitrogen until extraction 
of total RNA for determination f preprorenin m-RNA. 
L-NAME treatment ofclipped and sham-clipped rats. A total of 24 
animals were anaesthetized with methohexital (50 mg/kg) and the 
left kidney was exposed by an abdominal incision. In 12 animals 
sterile silver clips (Degussa) with an inner diameter of 0.2 mm 
were then placed on the left renal arteries. In 12 sham-clipped 
animals the left artery was touched only with forceps. The animals 
were awakened within 30 rain after the operation and the NO- 
synthase inhibitor L-NAME (40 mg/kg) or vehicle (0.9% NaC1) 
were applied by intraperitoneal injection, to achieve protracted ac- 
tion of the drug. For replacement of eliminated drug the injections 
of drugs were repeated at 12-h intervals during experiments. Dur- 
ing this period systolic blood pressure and heart rate were deter- 
mined with a BP recorder 8005 (Rhema, Hofheim, Germany) in 
the morning (2 h after previous application of drugs) and in the 
afternoon (8 h after previous application ofdrugs). Then, 48 h after 
operation the animals were killed by decapitation. Blood was col- 
lected from the carotid arteries for determination f PRA and both 
kidneys and adrenal glands were rapidly removed, kidneys 
weighed, cut in half and frozen in liquid nitrogen until extraction 
of total RNA for determination f preprorenin m-RNA. 
Determination ofpreprorenin m-RNA. Total RNA was extracted 
from the kidneys which were stored at -70 ~ C, according to the 
protocol of Chomczynski [3] by homogenization in 10 ml of solu- 
tion D [guanidine thiocyanate (4 M) containing 0.5% N-lauryl- 
sarcosinate, 10 mM EDTA, 25 mM sodium citrate and 700 mM fi- 
mercaptoethanol] with a polytron homogenizer. Sequentially, 1 ml 
of 2 M sodium acetate (pH 4), 10 ml phenol (water saturated) and 
2 ml chloroform were added to the homogenate, with thorough 
mixing after addition of each reagent. After cooling on ice for 15 
rain samples were centrifuged at10,000 g for 15 rain at 4 ~ C. RNA 
in the supernatant was precipitated with an equal volume of isopro- 
panol at -20  ~ C for at least 1 h. After centrigugation RNA pellets 
were resuspended in 0.5 ml of solution D, again precipitated with 
an equal volume of isopropanol at -20 ~ C and RNA pellets were 
finally dissolved in diethylpyrocarbonate-treated w r and stored 
at - 80 ~ C till further processing. Renin m-RNA was measured by 
RNase protection as described for erythropoietin [21]. A preprore- 
nin cRNA-probe containing 296 base pairs (bp) of exon I and II, 
generated from a pGEM-4 vector carrying aPstI-KpnI restriction 
fragment of a rat preprorenin cDNA [2], was generated by tran- 
scription with SP6 RNA polymerase (Amersham International, 
Amersham, UK). Transcripts were continuously labelled with 
[a32p]GTP (410 Ci/mmol; Amersham) and purified on a Sephadex 
G50 spun column. For hybridization total kidney RNA was dis- 
solved in a buffer containing 80% formamide, 40 mM piperazine 
N, NCbis(2-ethane sulphonic acid), 400 mM NaC1, 1 mM EDTA 
(pH 8). RNA (20 gg) was hybridized in a total volume of 50 gl at 
60~ for 12 h with 8.3• Bq radiolabelled renin probe. RNase 
digestion with RNase A and T1 was carried out at 20~ for 
30 min and terminated by incubation with proteinase K (0.1 mg/ 
ml) and sodium dodecyl sulphate (SDS, 0.4%) at 37~ for 30 
min. 
Protected preprorenin m-RNA fragments were purified by phe- 
nol/chloroform extraction, ethanol precipitation and subsequent 
800 
-~ 7oo 
r~ 
o 
600 
9 ~ soo 
~400 
0 
30o 
o 200 
100 
f 
/ /"lb 
J 
f 
f 
f 
/ 
t11.1 j "  
/ 
f 
/ 
.OS" I 
1 '  I '  
I0 2'0 ..... 4'0 
total RNA (~Jg) 
Fig. 1. Radioactivity counted in excised bands of acrylamid gel 
after autoradiography of RNase protection assay for renin m-RNA 
using different amounts of renal RNA standard 
electrophoresis on a denaturing 10% polyacrylamide g l. After 
autoradiography of the dried gel at -70 ~ C for 1 -2  days, bands 
representing protected renin m-RNA fragments were excised from 
the gel and radioactivity was counted with a liquid scintillation 
counter (1500 Tri-CarbTm, Packard Instrument Company, Down- 
ers Grove, Ill., USA). The number of counts per minute obtained 
from each sample of total kidney RNA was expressed relative to 
an external renin m-RNA standard included in each hybridization 
consisting of 20 ~g pooled RNA extracted from the 12 kidneys of 
6 normal Sprague Dawley rats. Figure I shows the results of an 
RNase protection assay for renin m-RNA using different amounts 
of the pooled RNA used as standard. 
Determination fact& m-RNA. The abundance of rat cytoplasma- 
tic fl-actin m-RNA in total RNA isolated from the kidneys was 
determined by an RNase protection assay exactly as described for 
preprorenin. An actin cRNA-probe containing the 76 nucleotide 
first exon and around 200 bp of the surrounding sequence was 
generated by transcription with SP6 polymerase from a pAM19 
vector carrying an AvaUHindIII restriction fragment of actin cDNA 
[21]. For one assay 2.5 gg RNA was hybridized under the condi- 
tions described for the determination f renin m-RNA. 
Densitometry ofpreprorenin m-RNA of adrenal glands. Levels of 
preprorenin m-RNA in adrenal glands were estimated by densi- 
tometry (elscript 400, Hirschmann, Unterhaching, Germany) of the 
autoradiographs, which were exposed for 2 -3  weeks. On each gel 
2 renin m-RNA standards, consisting of 2 and 0.5 gg pooled RNA 
extracted from 12 kidneys of 6 normal Sprague Dawley rats, were 
coanalysed and densitometric values related to the standard of 2 ~tg 
total RNA (Fig. 7). 
Determination fPRA. PRA was determined utilizing a commer- 
cially available radioimmunoassay kit for angiotensin I (ANGI) 
(Sorin Biomedica, Dfisseldorf, Germany). 
Experiments with primary cultures of mouse renal juxtaglomerular 
(JG) cells. JG cells were isolated as previously described [4] from 
the mouse strain C57B16, which expresses only the ten-1 gene. 
The isolated cells were cultured in 96-well plates exactly as de- 
scribed [4]. The cultures were incubated at 37 ~ C in a humidified 
atmosphere containing 5% COz in air. Experiments were per- 
formed after 20 h of primary culture. At this time the culture me- 
dium was removed and the cultures were washed once with culture 
medium. Fresh culture medium together with the drugs to be tested 
or their respective solvent controls were then added. 
Determination of renin secretion. At the end of the experiments, 
supernatants were collected and centrifuged at 500-1,000g at 
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room temperature to remove cellular debris. The supernatants were 
then stored at -20 ~ C for further processing. Cells were lysed by 
adding to each culture well 50 gl of phosphate-buffered saline 
(PBS) containing 0.1% Triton X-t00, and then shaking for 45 rain 
at room temperature. The lysed cells were stored at -20 ~ C for 
further processing. 
Renin secretion rates were estimated from the appearance rate 
of renin activity in the culture medium. To minimize differences 
among different cell culture preparations, renin secretion rates 
were calculated as fractional release of total renin [i.e. renin activ- 
ity released/(renin activity released + renin activity remaining in 
the cells)]. Renin activity was determined by its ability to generate 
ANGI from the plasma of bilaterally nephrectomized rats. ANGI 
was measured by radioimmunoassay (Sorin Biomedica). 
Determination of renin m-RNA in the cultured cells. At the end of 
the incubation experiments, cultured cells were placed on ice, the 
culture medium was removed and the cells were washed once with 
ice-cold PBS buffer. Then, the cells were lysed by adding 40 gl of 
an ice-cold buffer containing 2% Nonidet (NP 40), t0 mM Tris- 
HC1 (pH 8), 10 mM NaC1, 3 mM MgClz and 0.7% (vol/vol) mer- 
captoethanol t  each culture well and shaking for 15 min at 4 ~ C. 
The cellular lysates of two culture wells were pooled for the deter- 
mination of renin m-RNA. Cell nuclei were removed by centrifu- 
gation at 12,000 g and 4 ~ C for 3 rain. Of the cytoplasmic fraction 
3 gl was immediately used for reverse transcription, the remaining 
part was stored at -20 ~ C for cellular protein measurement. 
Renin m-RNA was measured using a reverse transcriptase- 
polymerase chain reaction method (RT-PCR) exactly as described 
recently [5]. In brief, a sense primer which spans the exon 6/exon 
7 border of the renin gene, and antisense primer located on exon 
8 were used, thus amplifying a 194-bp sequence. For quantifica- 
tion, an internal renin m-RNA standard (254 bp) was synthesized 
by inserting a 60-bp fragment into the normal renin m-RNA se- 
quence amplified by the RT-PCR exactly as described [5]. 
Reverse transcriptase r action. A 10-lxl aliquot of an ice-cold solu- 
tion containing 10 pmol of the antisense primer, I gg of yeast 
tRNA and 5 pg of the internal standard were added to 3 gl of the 
cytosolic fraction. Samples were heated 5 rain at 94 ~ C and then 
chilled on ice. Then, 10 gl of solution A were added and the sam- 
ples incubated at 37 ~ C for 1 h. Solution A consisted of 22 gl of a 
25 mM solution of desoxyribonucleotides, 45 gl of 5 • RT-buffer 
(supplied with the reverse transcriptase kit), 6 gl of the RNase 
inhibitor rRNasin (Promega), 9 gl of M-MLV Reverse tran- 
scriptase (Gibco-Bfl) and 20 gl of 0.1 M dithiothreitol. After incu- 
bation at 37 ~ C for t h, the reaction was stopped by heating the 
samples for 2 rain at 95 ~ C. 
Poiymerase chain reaction. To 3 gl of the cDNA solution, 2.5 gl 
of 10• PCR-buffer (supplied with Taq polymerase), t gl 
(10 pmol) of each primer, 4.5 lxl of a 25 mM MgC12 solution, 14 gl 
HzO and 5 gCi of [3H]dCTP were added: samples were overlay- 
ered with mineral oil, denatured at94 ~ C for 5 rain and cooled to 
65 ~ C for 5 min. After addition of 1 gl of 25 mM desoxyribo- 
nucleotide solution and 1.25 units of Taq polymerase (Boehringer 
Mannheim, Germany), 30 PCR cycles consisting of denaturation 
at 94~ (1 rain), annealing at 60~ (1 rain) and extension at 
72 ~ C (30 s) were performed. PCR was completed by a final exten- 
sion step of l0 rain at 72 ~ C. After PCR, the amplification products 
originating from renin mRNA or from the internal standard were 
separated by polyacrylamide g l electrophoresis. N,N'-Methylene- 
bis-acrylamide was replaced by dihydroxyethylene-bis-acrylam- 
ide. The bands were excised, solubilized in 0.025 M periodic acid 
and radioactivity assessed in a r-counter. The radioactivity incor- 
porated by renin mRNA was routinely related as a percentage to
the radioactivity incorporated by the 5 pg of internal standard. 
Statistics. ANOVA t-test was used for interindividual comparisons 
and student's paired t-test for intraindividual comparisons. 
P < 0.05 was considered significant. 
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Fig. 2. Time course of plasma renin activity (PRA, upper panel) 
and renin m-RNA levels (lower panel) in clipped and contralateral 
- kidneys (0.2 mm clip). Renin m-RNA levels are expressed in rela- 
tion to an external standard. Data are means + SEM of 4 animals 
at each time point 
Results 
Renin gene expression was studied in male Sprague 
Dawley rats with either normal renal blood flow, or with 
unilateral reduction of blood flow induced by silver clips 
with an inner diameter of 0.2 mm. To find the time point 
of maximal stimulations of renal renin gene expression 
and renin secretion we first measured renin m-RNA lev- 
els in the stenosed and in the contralateral kidneys, as 
well as PRA levels 1, 2, 5 and 10 days after setting the 
clips. As shown in Fig. 2, the unilateral reduction of re- 
nal blood flow caused an increase of renin m-RNA lev- 
els of the clipped kidneys, which reached a maximum 
(550% of basal level) 2 days after setting the clip and 
returned to control values within 10 days (Fig. 2). In 
contralateral kidneys renin m-RNA levels were sup- 
pressed to about 30% of control values after 1 day and 
this reduction of renin m-RNA remained throughout the 
10 days of the experiments (Fig. 2). PRA levels paral- 
leled the m,RNA levels in the stenosed kidneys. For fur- 
ther experiments studying the influence of EDNO we 
chose, therefore, a time interval of 48 h after setting the 
clips, when PRA levels and renin m-RNA levels in the 
clipped kidneys were maximally stimulated, while renin 
m-RNA levels in the contralateral kidneys were signifi- 
cantly suppressed. 
To inhibit endogenous EDNO formation we used in- 
traperitoneal injections of [.-NAME (40 mg/kg twice a 
day) which has been found to be a tolerable inhibitor of 
NO-synthase in vivo [22]. To assess possible side effects 
of EDNO inhibition with relevance for the control of the 
renin system, such as an increase of blood pressure [22] 
or reflex inhibition of sympathetic outflow, we measured 
arterial pressure and heart rates during the 2 days of 
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Fig. 3. Systolic blood pressure of sham-clipped rats (A) and rats 
with left renal artery clip (C) and heart rate of sham-clipped rats 
(B) and rats with left renal artery clip (D) after vehicle (open 
symbols) and nitro-L-arginine-methylester (L-NAME) (closed sym- 
bols) treatment. Data are means -+ SEM of 6 animals in each ex- 
perimental group. Injection of L-NAME (40 mg/kg) is indicated 
by arrows). * P < 0.05 
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Fig. 4. Upper panel shows PRA of sham-clipped vehicle-injected 
and sham-clipped L-NAME-(40 mg/kg, twice a day)-injected rats 
after 48 h. PRA is expressed as ng angiotensin I (ANGI)/h • ml. 
Lower panel shows PRA of clipped, vehicle-injected and clipped 
L-NAME-(40 mg/kg, twice a day)-injected rats after 48 h. Data are 
means + SEM of 6 animals in each experimental group. 
* P < 0.05 
treatment with L-NAME. As shown in Fig. 3, L-NAME 
caused a significant increase of systolic blood pressure, 
but had no measurable ffect on heart rate in animals 
with nonclipped kidneys. Clipping of one renal artery 
did not change heart rates, but led to an increase of sys- 
tolic blood pressure in vehicle-injected animals (Fig, 3). 
Again L-NAME did not change heart ra es in this group 
of rats whilst the increase of blood pressure upon clip- 
ping of one renal artery was the same in vehicle- and in 
L-NAME-injected rats. 
Treatment with L-NAME led to a significant 
decrease of basal values for PRA from 8 + 1.2 ng 
ANGI .h  -a .ml  1 (mean +SEM;  n=6)  to 2.8 
+ 0.65 ng ANGI .  h -1 9 ml ~ (n = 6) (Fig. 4). Clipping 
of the left renal arteries for 2 days increased PRA values 
to 35 _+ 5.4 ng ANGI 9 h -~ 9 m1-1 (n = 6) in vehicle-in- 
jected rats, and to 13 + 3.6 ng ANGI 9 h -~ 9 m1-1 (n = 
6) in L-NAME-treated animals (Fig. 4). 
Renin m-RNA levels in the kidneys and in the adre- 
nal glands were analysed by RNase protection. RNase 
protection assays for renin m-RNA on total RNA were 
performed using a 296-bp antisense riboprobe of rat pre- 
prorenin m:RNA. Figure 5 (upper panel) shows a repre- 
sentative autoradiograph of such an RNase protection 
assay for the left and right kidneys isolated from non- 
clipped vehicle-injected, nonclipped L-NAME-treated, 
left-side clipped vehicle-injected and left-side clipped L- 
NAME-treated rats. For comparison and quantification 
20 btg of an aliquot from a pool of total RNA isolated 
from 12 kidneys of 6 normal adult male rats was coana- 
lysed on the gel as an external standard (St). It is evident 
from Fig. 5 that renin m-RNA was decreased in the kid- 
neys from the L-NAME-treated nonclipped rat when 
compared with the nonclipped vehicle-injected animal. 
Left renal artery clipping led to a marked increase of 
renin m-RNA in the clipped kidney and to a suppression 
of renin m-RNA in the contralateral kidney in vehicle- 
Fig. 5. Upper panel shows an autoradiograph of RNase protection 
assay for renin m-RNA with total renal RNA isolated from vehi- 
cle-injected, sham-clipped (contr.), L-NAME-injected, sham- 
cfipped (L-NAME) vehicle-injected clipped (clip), L-NAME-in- 
jected, clipped (L-NAME + clip) rats. 20 pg of total RNA were 
analysed in each assay. R, Right (contralateral) kidney; L, left 
(clipped) kidney; St, 20 pg of RNA standard. Lower panel shows 
the corresponding autoradiograph of RNase protection assay for 
/~-actin m-RNA. 2.5 btg of total RNA are analysed in each assay. 
St, 2.5 Mg of RNA standard 
injected rats. In the L-NAME-treated animals the in- 
creases and suppression f renin m-RNA levels in the 
ipsilateral and contralateral kidneys, respectively, were 
markedly attenuated. For further quantification, pro- 
tected fragments were excised from the dried gels and 
measured by assessing the fi radioactivity. After back- 
ground subtraction the radioactivity of each band was 
related to that of the external standard RNA and ex- 
pressed as a percentage of the standard. Average renin 
m-RNA levels that were quantified in this way for left 
and right kidneys isolated from the rats of the four ex- 
perimental groups are summarized in Fig. 6. In non- 
clipped animals there was no systematic side difference 
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Fig. 6, Upper panel shows renal renin m-RNA levels expressed in 
relation to an external standard in sham-clipped rats injected with 
vehicle (0.9% NaC1) or with L-NAME (40 mg/kg) twice a day for 
48 h. Lower panel shows renal renin m-RNA levels expressed in 
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Fig. 7. Effect of L-NAME (40 mg/kg, twice a day) on adrenal renin 
m-RNA levels expressed in relation to an external standard (2 txg 
of total RNA from control animals). Data are means + SEM. 
Number of animals is indicated in the bottom of bars 
of renin m-RNA levels between the two kidneys and L- 
NAME treatment led to a 35% decrease of basal renin 
m-RNA levels (Fig. 6, upper panel). In vehicle-injected 
rats clipping of the left renal artery with a 0.2-ram clip 
increased renin m-RNA levels by 450% over the basal 
level in the clipped kidney and decreased m-RNA levels 
to 16% of the basal level in the contralateral right kid- 
neys (Fig. 6, lower panel). In L-NAME-treated animals 
renin m-RNA levels in the clipped kidney rose by 220% 
over the basal value of vehicle-injected rats and renin 
m-RNA levels in the contralateral kidneys decreased to 
50% of the basal value. For control we also analysed the 
expression of a house-keeping ene such as fl-actin in 
vehicle- and L-NAME-treated rats. As illustrated in 
Fig. 5 (lower panel) there was no consistent difference 
in the abundance of actin m-RNA in total RNA isolated 
from the kidneys of the animals of the four experimental 
groups. 
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Fig. 8. Upper panel shows the effect of forskolin (10 ~tM) and of 
sodium nitroprusside (SNP, 100 gM) on 20 h renin secretion from 
cultured mouse renal juxtaglomemlar (JG) cells. Renin secretion 
is expressed as the percentage of the total renin activity present in 
the cultures. Data are means + SEM of 8 experiments done with 
different cell preparations. Each experiment represents the mean 
of quadruplicate culture wells. Lower panel shows the effect of 
forskofin (10 pM) and of SNP (100 gM) on renin m-RNA levels 
in the primary cultures of mouse renal JG cells. Data are means 
-+ SEM of 8 different culture preparations. To minimize differ- 
ences among different cell culture preparations, renin m-RNA lev- 
els in the presence of forskolin and of SNP are expressed as a 
percentage of the renin m-RNA found in the cultures treated with 
vehicle only 
Besides the kidney, the adrenal gland has been recog- 
nized also as a relevant site of renin gene expression. 
We therefore analysed renin m-RNA levels in total RNA 
isolated from the adrenal glands of the L-NAME-treated 
and of vehicle-injected rats. Because of the rather low 
abundance of renin m-RNA in total RNA isolated from 
adrenal glands the long exposure time of the autoradio- 
graph did not allow quantification of the protected frag- 
ments by assessing the /~ radioactivity. Therefore the 
bands on the autoradiograph were analysed by laser den- 
sitometry and the values obtained were given as a pro- 
portion of that obtained with 2 gg of the renal standard 
RNA which was coanalysed on each gel. To acertain 
linearity of densitometric evaluation, 0.5 gg of standard 
RNA were also coanalysed and given as a proportion of 
2 Ixg of standard RNA (Fig. 7). Adrenal renin m-RNA 
levels analysed by this way displayed a rather broad 
variance when compared with renal renin m-RNA levels. 
In sham-clipped vehicle-injected rats the abundance of 
renin m-RNA in adrenal glands was on average 2% of 
the value found for the kidneys. By ANOVA we found 
no difference of adrenal renin m-RNA levels between 
sham-clipped and clipped rats neither during vehicle nor 
during L-NAME injection. To examine the overall effect 
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of L-NAME treatment on adrenal renin gene expression, 
therefore, we pooled the data for sham-clipped and 
clipped animals in both the vehicle and the L-NAME 
groups. As shown in Fig. 7 there was a tendency towards 
lower adrenal renin m-RNA levels in L-NAME-treated 
rats when compared with vehicle-injected animals. This 
difference, however, did not reach the level of statistical 
significance (P > 0.05). 
The results described so far have not allowed distinc- 
tion between direct and indirect effects of EDNO on re- 
nin secretion and renin gene expression. Therefore, we 
attempted to examine possible direct effects by examin- 
ing the influence of the NO-donor nitroprusside on iso- 
lated renal JG cells. To this end, primary cultures of 
mouse renal JG cells were incubated with sodium nitro- 
prusside (SNP, 100 gM) for 20 h and renin secretion was 
measured and cellular renin m-RNA levels were deter- 
mined by RT-PCR as described recently [5]. For compar- 
ison we also examined the effects of the adenylate cy- 
clase activator forskolin (10 ~tM), which has recently 
been shown to stimulate renin secretion and renin gene 
expression in isolated JG cells [5]. As shown in Fig. 8 
(upper panel) SNP and forskolin produced comparable 
increases of renin secretion. Both drugs also led to sig- 
nificant (P < 0.01) increases of cellular renin m-RNA 
levels, with the difference that forskolin was more potent 
than SNP (Fig. 8, lower panel). For control we also mea- 
sured total RNA synthesis in the cultured cells by pulse 
experiments with [3H]uridine. In these experiments we 
found no effect of 100 ~tM SNP or 10 gM forskolin on 
total RNA synthesis. 
Discussion 
It was the aim of this study to examine the effect of 
EDNO on renin gene expression in the kidney under 
both basal conditions and under stimulation by a reduc- 
tion of renal perfusion induced by unilateral 0.2-ram ar- 
tery clips. In the presence of left renal artery clips renin 
m-RNA levels increased transiently in the clipped kid- 
ney with a time course which was similar to the time- 
dependent changes of renin secretion found in experi- 
mental Goldblatt-hypertension [6]. In parallel, renin m- 
RNA levels were constantly suppressed in the contralat- 
eral kidney. Similar temporal patterns of renal renin 
m-RNA levels have already been described for unilateral 
renal artery clipping [12] and for aortic coarctation [13]. 
Inhibition of endogenous EDNO formation was 
achieved with intraperitoneal injections of L-NAME, a 
well-established inhibitor of NO-synthase in vivo [22]. 
We found that administration of L-NAME to the con- 
scious rats significantly decreased PRA and renal renin 
m-RNA levels under basal conditions, suggesting inhibi- 
tion of basal renin secretion and of basal renal renin gene 
expression by L-NAME. Inhibition of endogenous 
EDNO formation has been reported to increase blood 
pressure [22] and to decrease heart rate [22], which 
could suggest a reflex inhibition of sympathetic activity. 
Both reactions could in principle lead to a decrease of 
renin secretion and of renin gene expression, because 
blood pressure and renal nerve activity have been found 
to be activators of renin secretion and of renin gene ex- 
pression [6, 12, 17, 29]. In our experiments we did not 
observe an effect of L-NAME on heart rate, which we 
considered as an indirect measure for sympathetic activ- 
ity. Systolic blood pressure, however, increased signifi- 
cantly during treatment with L-NAME and, therefore, 
we can not definitively exclude the possibility from our 
experiments hat the effects of L-NAME on basal PRA 
and on basal renal renin m-RNA levels were mediated 
by an increase of blood pressure. Changes of blood pres- 
sure or of sympathetic activity, however, are rather un- 
likely to account for the attenuation of renin secretion 
rates and renal renin m-RNA levels in animals with uni- 
lateral renal artery clips, because in those animals there 
were no differences in heart rates and in systolic blood 
pressures between the vehicle- and the L-NAME-treated 
animals. We infer, therefore, that the effects of L-NAME 
on the renin system in 2K-1C rats were primarily due 
to inhibition of intrarenal EDNO formation, rather than 
indirectly mediated by a side effect. This conclusion is 
supported by the previous findings that inhibitors of 
EDNO formation attenuate renal renin secretion in vitro 
in isolated perfused rat kidneys [8, 15, 23] and in cocul- 
tures of renal JG and endothelial cells [11], as well as in 
vivo in dogs upon systemic and intrarenal application 
[16, 18]. Conversely, our findings now show that EDNO 
is a stimulator of renin secretion and of renin gene ex- 
pression in renal JG cells (Fig. 8). Thus, it appears likely 
that the in vivo effects of L-NAME are at least in part 
related to a direct stimulatory effect of EDNO on renal 
JG cells. In vivo experiments and experiments with iso- 
lated perfused rat kidneys have, moreover, produced evi- 
dence that the stimulation of renin secretion upon 
lowering the perfusion pressure is particularly sensitive 
to inhibition of endogenous EDNO production [18, 23]. 
Our data do confirm this notion and now provide the 
first evidence that the same holds for renin gene expres- 
sion in the hypoperfused kidney. Thus, EDNO appears 
to be an activator of renal renin gene expression, and is 
involved in the control of the renin gene via the perfu- 
sion pressure. In this study we found that L-NAME at- 
tenuated the increases of renal m-RNA levels and of re- 
nin secretion in 2K-1C animals by about 50%. This 
value is close to the inhibition by L-NAME of renin re- 
lease stimulated by low renal artery pressure in con- 
scious dogs [18]. Intrarenal application of NO-synthase 
inhibitors in anaesthetized dogs [16], or in isolated per- 
fused kidneys, [23] has been found to decrease the renin 
secretion response to low perfusion pressure by 70-  
80%. It is not unlikely, therefore, in our experiments 
with conscious rats that EDNO production was not com- 
pletely blocked, raising the possibility that a more effec- 
tive inhibition of the NO system would further decrease 
renin gene expression in response to hypoperfusion of 
the kidney. 
Interestingly, renin m-RNA levels in the contralater- 
als as opposed to the stenosed kidneys in L-NAME- 
treated animals were not as strongly suppressed as in 
vehicle-injected rats. This may indicate that there was a 
minor release of factors that cause suppression of renin 
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gene expression in contralaterals as opposed to stenosed 
kidneys. Although these factors have not yet been une- 
quivocally characterized, angiotensin II (ANGII) is con- 
sidered to be a likely candidate [20]. Our findings would 
not disagree with this concept, since L-NAME markedly 
suppressed renin secretion rates and thus the formation 
of systemic ANGI I  in the 2K-1C animals. 
Besides the kidneys, the adrenal glands also have 
been recognized as a relevant site of renin gene expres- 
sion. Moreover, it has been found recently that both re- 
nal and adrenal renin gene expression are stimulated by 
low salt intake [7, I0], suggesting that adrenal and renal 
renin gene expression can in principle be regulated by 
common factors. This was the reason for us to also con- 
sider a possible influence of EDNO on adrenal renin 
gene expression. Indeed there was a tendency of adrenal 
renin m-RNA levels to decrease during L-NAME treat- 
ment, suggesting that EDNO might also be a stimulator 
of renin gene expression in adrenal glands. With 12 ani- 
mals in each group, however, this effect did not reach 
statistical significance. It should be recalled in this 
context that the inhibitory effect of L-NAME on renal 
renin gene expression was also moderate under basal 
conditions and was more pronounced uring stimulation 
by unilateral renal artery clipping, a manoeuvre which 
in turn had no effect on adrenal renin gene expression. 
The question arises whether the stimulatory effect of 
EDNO on renin gene expression is like the effect of 
cAME a direct effect or one that is secondary to the 
stimulation of renin secretion by EDNO. In fact several 
possible modes of interdependent and independent con- 
trols of renin secretion and of renin synthesis have been 
previously reviewed [25]. Due to the poor understanding 
of the control of the renin gene on the level of JG cells, 
however, all of these models await further confirmation. 
Recently, we have found that in primary cultures of 
mouse renal JG cells the secretion and the synthesis of 
renin are not strictly linked [4], suggesting that renin 
secretion and renin gene expression might be indepen- 
dently regulated from each other. In this view our pre- 
sent findings would suggest hat EDNO is an activator 
of renin secretion and of renin gene expression in vitro 
and in vivo, which appears to be involved importantly 
in the control of renin gene expression by the renal per- 
fusion pressure. A direct stimulatory effect of EDNO on 
transcriptional ctivity was in fact recently demonstrated 
for PC12 cells [19]. To examine the mechanisms along 
which EDNO could activate renin gene expression on 
the level of JG cells will be a task for our future work. 
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